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EXPRESSION OF AXONAL GABAa RECEPTORS IN RAT DORSAL ROOT DURING 
DEVELOPMENT. Sean P. Roddy, Kaoru Sakatani, and Jeffery D. Kocsis. Department 
of Neurology and Section of Neurobiology, Yale University, School of Medicine, New 
Haven, CT, and VA Medical Center, West Haven, CT. 
During the course of development, rat optic nerve fibers are depolarized by 7- 
aminobutyric acid (GABA); the depolarizing actions of GABA are very pronounced in 
the neonate, but are virtually absent in the adult. In contrast to these central nervous 
system myelinated axons, rat dorsal root axons respond with a large depolarization upon 
application of GABA even in the adult. We examined the GABA-induced depolarization 
in developing rat lumbar dorsal roots using a modified sucrose-gap technique. The 
dorsal roots displayed distinct GABA-induced depolarizations from birth through 
adulthood. Specifically, the depolarization was 2.51 ± 0.14 mV at one week, 1.16 ± 
0.09 mV at two weeks, and 5.60 ± 0.40 mV at four weeks of age. However, the 
potential change observed in the four week-old was no different from that of a ten week- 
old adult rat. Comparing the depolarizations in the three time periods, the time-to-peak 
value in the one week-old was shorter than the others and was accompanied by a plateau 
level less than that at peak. Application of GABA to ventral spinal roots had no effect 
confirming that it is the primary afferent sensory fibers and not the motor fibers which 
are GABA-sensitive. Stimulation for release of endogenous GABA and blockade of 
GABA uptake by nipecotic acid (NPA) produced no depolarization in dorsal root. This 

is in contrast to the optic nerve in which NPA elicits a distinct depolarization. These 
results demonstrate that unlike the optic nerve whose responses to GABA attenuate 
during the first few weeks and which displays endogenous release of GABA, peripheral 
dorsal roots exhibit GABA-sensitivity that peaks in the mature adult and dorsal root 
excitability during development is not influenced by GABA released from Schwann cells. 
The transient decrease in the amplitude of GABA-induced depolarization between one 
and two weeks of age correlates with myelination and with growth of fibrous connective 
tissue. The increase in magnitude of depolarization between two and four weeks of age 
may be due to increase in GABAa receptor density, a change in the electrochemical 
gradient, or a change in the subunit structure of the GABAa receptor. 
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Neurotransmitter release and subsequent receptor activation have been traditionally 
localized to the synapse, and receptors have been observed solely on dendrites and cell 
bodies. However, there has been evidence for the presence of asynaptic GABAa 
receptors on both myelinated and unmyelinated axons (Brown & Marsh, 1978, Morris 
et al., 1983, Bhisitkul et al., 1987). In fact, GABAa receptor density along the length 
of the axon is often high when compared with endogenous stores of the neurotransmitter. 
In the central nervous system, GABAa receptors have been shown to be 
transiently present on rat optic nerve axons during development and postulated to play 
a role in the terminal arborization patterning along the optic tract (Sakatani et al., 1992). 
These receptors appear to affect axonal excitability through a shunting of excitatory 
current and thus can exert a pre-synaptic inhibitory effect. The specific physiologic role 
for axonal GABAa receptors is currently unclear. 
GABA Pharmacology and Metabolism 
7-Aminobutyric acid (GABA) is the principal inhibitory neurotransmitter in the 
mammalian central nervous system (Krnjevic, 1974, Snyder, 1984). GABA exerts this 
inhibition by interacting with the two known GABA receptor subtypes, GABAa and 
GABAb (Simmonds, 1983, Bowery et al., 1984, Bormann, 1988, Stephenson, 1988). 
The GABAa receptor is an integral membrane protein intimately associated with a 
chloride ionophore; whereas the pharmacologically distinct GABAb receptor regulates 
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calcium and/or potassium channel activity by modulation of adenylate cyclase through 
interaction with a GTP binding protein (Bormann, 1988). Unlike the monoamines which 
are present in nanomole/gram levels in the central nervous system, GABA is present in 
^imole/gram concentration levels (Tallman & Gallager, 1985). GABA does not cross the 
blood brain barrier in any significant amount. 
GABA is synthesized in the neuron by the a-decarboxylation of L-glutamic acid, 
a major excitatory neurotransmitter (Cooper et al., 1986). This reaction requires the 
enzyme glutamic acid decarboxylase (GAD) and the cofactor pyridoxal-5’-phosphate. 
Optimum reaction rates occur at pH 6.5. The reverse reaction has not been demonstrable 
either in vivo or in vitro and GAD is present only in retinal tissue and the central nervous 
system. GABA-transaminase (GABA-T) is the enzyme responsible for catalyzing the 
breakdown of exogenous GABA to succinyl semialdehyde; it requires pyridoxal-5’- 
phosphate as a cofactor and functions optimally at pH 8.2. Cell fractionization 
techniques and electron microscopy have shown that GABA-T is found in association 
with mitochondria and GAD is found in association with the synapse. GAD has a lower 
affinity for pyridoxal-5’-phosphate than does GABA-T so a reduction in the levels of this 
cofactor leads to epileptiform seizure activity in animal models. 
GABA Receptor Subtypes 
The GABAa receptor is a hetero-oligomeric protein believed to be a member of 
a gene superfamily (along with the nicotinic acetylcholine and the strychnine-sensitive 
glycine receptor) of ligand-gated ion channels who demonstrate significant DNA sequence 
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homology (Barnard et al., 1987, Schofield et al., 1987, Levitan et al., 1988, Pritchett 
et al., 1989). This receptor has been implicated in both pre-synaptic and post-synaptic 
inhibition. The GABAa channel mediates chloride transport across the membrane in 
response to agonist binding with receptor activation occurring on a millisecond time 
scale. GABAa receptors are widely distributed throughout the brain, but are most highly 
concentrated in the granule cell layer of the cerebellum and the frontal cortex of the 
cerebrum (Bowery et al., 1987). 
In addition to GABA, the GABAa agonist binding site recognizes muscimol (5- 
aminomethyl-3-hydroxyisoxazole), 3-aminopropanesulfonicacid (3-APS), 5-aminovaleric 
acid (DAVA), isoguvacine and 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol (THIP) 
(Morris et al., 1983, Bormann, 1988) and is competitively antagonized by bicuculline, 
a plant alkaloid, (Davidoff, 1972, De Groat, 1972, Barolet et al., 1985). The convulsant 
drugs picrotoxin and t-butyl-bicyclophosphorothionate (TBPS) are non-competitive 
antagonists that act at a site proposed to be on the chloride ionophore (Smart & 
Constanti, 1986). There are binding sites for chloride ions on the GABAa receptor near 
or within the pore which appear to regulate the flow of anions through the channel 
(Bormann et al., 1987). Single channel recording studies indicate that two anion-binding 
sites are present on the GABAa receptor complex. 
The GABAa response can be potentiated by the binding of several other classes 
of drugs to specific sites distinct from the agonist binding site. Binding at the 
potentiating sites does not in itself cause opening of the chloride ionophore and both the 
potentiating site and the agonist binding site must be occupied concurrently for receptor 
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activation. However, a significantly smaller concentration of agonist is required for a 
given response when the potentiating site is occupied. Whereas barbiturates increase the 
chloride conductance by an increase in the mean open time of the chloride channel, 
benzodiazepines, when bound to the receptor in conjunction with a GABAa agonist, 
increase the current through the GABAa receptor channels by increasing the frequency 
at which the ionophore opens (Study & Barker, 1981, Ong & Kerr, 1984, Stephenson, 
1988). Two other classes of compounds have been shown to interact with the GABAa 
receptor to produce a potentiating effect. These are the antihelminthic avermectins (Pong 
& Wang, 1982), and steroids including progesterone derivatives (Lambert et al., 1987) 
and the steroid anesthetic alfaxalone (Harrison & Simmonds, 1984). 
Unlike the GABAa receptor, the GABAb receptor is distinct from the ion channel 
upon which it exerts an effect (Wojcik & Neff, 1984, Hill, 1985). It functions in 
inhibition both pre-synaptically and post-synaptically by the use of a second messenger 
system, specifically a pertussis toxin-sensitive GTP-binding protein, to cause an increase 
in outward potassium conductance and/or a decrease in inward calcium conductance 
(Inoue et al., 1985, Karbon & Enna, 1985, Holz et al., 1986). In the brain, GABAa 
receptors outnumber GABAb receptors except in areas such as the molecular layer of the 
cerebellum, superior colliculus, globus pallidus, lateral amygdaloid nucleus, and the 
pontine nucleus where GABAb receptors predominate (Wilkin et al., 1981, Bowery et 
al., 1983). In the spinal cord, GABAa receptors are located in the dorsal and ventral 
laminae I-X in contrast to GABAb receptors which are concentrated in laminae I-IV. 
GABAb receptors are bicuculline-insensitive, are activated stereospecifically by (-)- 
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baclofen (4-amino-3-[4-chlorophenyl]-butanoicacid), have no known specific antagonists, 
and are not potentiated by benzodiazepines or barbiturates (Bormann, 1988). 
GABAA-Mediated Inhibition 
The direction of ion flow through a chloride-selective membrane pore depends on 
the electrochemical gradient for chloride which is determined by both the resting 
membrane potential and the chloride concentration gradient (Hille, 1984). There is an 
uneven distribution of chloride across the cell membrane with concentrations of 
extracellular chloride being 10-20 times higher than intracellular concentrations. The 
cytoplasm has a negative potential relative to the extracellular space. The concentration 
gradient drives the anion intracellularly while the negative charge drives the anion 
extracellularly. Activation of the GABAa channel in response to agonist binding causes 
an increase in chloride conductance and if membranes were dependent only on chloride, 
the resulting current would change the cell membrane potential, bringing it toward a new 
equilibrium state known as the equilibrium potential for chloride or EC1. The EC1 can also 
be thought of as that membrane potential, in a membrane permeable only to chloride 
ions, at which there is no net movement of chloride ions. The EC1 can be determined by 
using the Nemst equation: 
^ In iff1 
F [Cl] 
R is the Gas constant (8.314 JK'mol'1) 
T is the temperature in Kelvin 
F is the Faraday constant (9.648 x 104 Cmol'1) 
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[Cl']j is the intracellular chloride concentration 
[Cl ]0 is the extracellular chloride concentration. 
The real membrane potential (EJ, however, depends on all ion conductances (gion) 
in the cell. This can be illustrated by combining the Nemst and Goldman equations to 
give the following equation: 
_ Sno^No +8kEr+Sci^ci +Shco2^hco3+■ ■ • 
%Na +Sk +Sci +8hCOz + ‘" 
When GABAa channels open, the relative conductance of chloride is so large in 
comparison to all other conductances that the membrane potential becomes that of EC1. 
If EC1 alone was used to determine a new equilibrium state, this would assume that 
GABA induced no other ion transport. There is, however, evidence for HC03' 
conductance through the GABAa channel (Sakatani et al., 1992). It is therefore more 
appropriate to use EGABA than EC1. 
Generally speaking, there is a hyperpolarization in cortical neurons but a 
depolarization in sympathetic and dorsal root ganglia, primary afferent terminals 
(Simmonds, 1983) and optic nerve (Sakatani et al., 1992) in response to GABA. For 
example, studies in primary afferent frog and rat cell bodies have determined EGABA to 
be -35mV (Levy, 1977). In this case, since EGABA is less negative than the resting 
membrane potential, there must be an outwardly directed chloride conductance and a 
depolarization of the primary afferent terminal in response to agonist binding. 
Axonal GABAa receptors appear to exert their inhibitory effect pre-synaptically. 
That is, activation of these receptors decreases axonal excitability and can decrease the 
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probability of propagation of an excitatory stimulus across to the subsequent synapse. 
GABA can inhibit depolarization to threshold (a critical membrane potential less negative 
than that at rest at which a cell generates an action potential) by two mechanisms. The 
first occurs generally in cortical neurons where EGABA is more negative than rest. 
Activation of the GABAa channels results in hyperpolarization and the membrane 
potential is brought further away from threshold reducing the probability of generating 
an action potential in the event of a depolarizing stimulus. The second occurs regardless 
of change in membrane potential. GABAa channels stabilize the cell membrane and 
shunt current in response to excitatory stimuli through an appropriate increase in chloride 
conductance. Shunting is an extremely effective means of inhibition even when EGABA 
is between the baseline membrane potential and threshold for a given neuron. The cell 
becomes essentially clamped at the EGABA while GABAa channels are activated (White, 
1990). Whenever an excitatory potential is applied to the cell, the chloride conductance 
dissipates the depolarizing current and an action potential is not generated. 
GABAa Receptor Desensitization 
As stated above, agonist binding to the GABAa receptor results in an increased 
chloride conductance, but this conductance will fade in a biphasic manner even if the 
concentration of the agonist is maintained (White, 1990). This decrease is called 
desensitization and can be interpreted as a change in the receptor from an active to an 
inactive state. At GABA concentrations greater than 10 piM, currents in adrenal 
chromaffin cells through GABAa channels decreased following initial peak response 
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(Bormann et al., 1985). The time course of desensitization was described by the sum 
of two exponentials indicating that GABAa receptors have both a fast and a slow 
desensitization as evidenced by the biphasic fading response. The first decrease is the 
"fast" desensitization and the decrease after the initial change in rate is the "slow" 
desensitization (White, 1990). This change in current is dependent upon agonist 
concentration, as shown by the fact that higher concentrations produce more rapid 
desensitizations. Recovery from the desensitized state was described approximately as 
a single exponential. In the presence of agonist, a GABAa channel in a dorsal root 
ganglion neuron will open and produce an inward current that immediately decreases at 
a given rate. After a given period of time, the rate then shifts abruptly to a more gradual 
rate. A concentration of at least 10 GABA is necessary for any desensitization at 
all. It has been proposed that rapid desensitization is due to a cAMP-dependent protein 
phosphorylation and slow desensitization is due to some other structural change upon 
dephosphorylation, but this remains speculative (Tehrani et al., 1989). 
Axonal GABAa Receptors 
GABAa receptors have been identified on the axons of dorsal but not ventral roots 
indicating selective expression on sensory nerve fibers (Bhisitkul et al., 1987). This 
raises questions as to why they are present and what their function is. Three possibilities 
have been proposed. The first assumes that receptors in the axonal membrane outside 
the spinal cord and at points distant from the axon terminal are not intended to be 
physiologically active. Instead, these proteins, which are integrated into the plasma 
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membrane in the cell body, are merely being transported to their intended site of function 
at a central synapse. The next theory addresses the possibility of synaptic drift. That 
is, axonal GABAa receptors are activated by distally diffused neurotransmitter released 
at the synapse. This would produce a further decrease in excitability along the axon. 
This theory seems unlikely due to the extreme distance between the site of release of 
GABA in the spinal cord and the known location of the peripheral axonal GABAa 
receptor adjacent to the dorsal root ganglion. The last theory assumes that non-neuronal 
cells such as the Schwann cell release GABA in an attempt to modulate transmission 
along the sensory fibers. This may take place either during normal adult life as a 
secondary modification of sensory input or during early postnatal development as a 
means of effecting the terminal arborization patterns of neurons by influencing neurite 
formation in growth cones. 
GABAa Receptor Expression During Development 
GABAa receptors have been shown to have an age-dependent pattern of 
expression in rat optic nerve. In a study by Sakatani et al. (1992), the depolarization in 
the membrane potential in a ten day postnatal (P-10) rat after application of 1 mM GABA 
averaged 5.7 mV, and this response was much attenuated at P-14. The absence of a 
response after two weeks of age indicates a progressive developmental decrease in 
GABAa receptor expression in the central optic nerve fibers. 
Application of nipecotic acid (NPA) has been shown not only to block GABA 
uptake mechanisms (Johnston et al., 1976), but also to stimulate the release of GABA 

10 
into the extracellular space (Brown et al., 1980). Through the use of NPA, Sakatani et 
al. (1992), demonstrated that endogenous stores of GABA can depolarize optic nerve 
axons during the first two weeks of life. NPA, when applied in 1 mM concentrations 
to developing optic nerve, induced up to a 4.0 mV depolarization in the first week of life 
but this effect was not present after the second week. 
Purpose 
GABA has been shown to play a transient role in the developing central nervous 
system of rats, as demonstrated by its effects on the optic nerve. This GABAa receptor- 
induced effect can be reproduced through blockade of GABA uptake mechanisms by 
superfusion with NPA. This may be due to some role that GABA plays in neuronal 
calcium levels and neurite extension in the optic nerve during development. The adult 
rat optic nerve, on the other hand, does not appear to express the GABAa receptor 
whereas the adult dorsal root in the peripheral nervous system does. The question 
remains as to whether there is a such a change in the presence of the GABAa receptor 
in the early postnatal dorsal root. This study attempts to assess if there is any difference 
in GABAa receptor expression in dorsal root during development. Also, to assess the 
possibility of endogenous GABA release as a means of altering axonal excitability and 





Dissection and Solutions 
Wistar rats (seven days to ten weeks old) were deeply anesthetized with sodium 
pentobarbitol (60 mg/kg) by either intraperitoneal or subcutaneous injection and 
exsanguinated by carotid section. The spinal cord was exposed by laminectomy and the 
dura mater was incised. The fourth and fifth lumbar spinal roots were excised without 
ganglia. The roots were placed in a modified Krebs’ solution at room temperature (20- 
24°C), saturated with a gas mixture of 95% 02 and 5% C02 and allowed to equilibrate 
in the dissecting solution for 30-40 minutes. 
The modified Krebs’ solution was composed of (in mM): 124 NaCl, 3 KC1, 2 
CaCl2, 2 MgCl2, 1.3 NaH2P04, 26 NaHC03, 10 dextrose, and pH 7.4. In addition, 
solutions containing 7-aminobutyric acid (GABA ; 1 mM), muscimol (1 mM), baclofen 
(100 pM), bicuculline (100 pM), and nipecotic acid (NPA; 1 mM) were made by adding 
the appropriate amount of the drug to the Krebs’ solution. Isotonic sucrose solution was 
composed of 320 mM sucrose and isotonic-KCl solution was composed of (in mM): 3 
NaCl, 124 KC1, 2 CaCl2, 2 MgCl2, 1.3 NaH2P04, 26 NaHC03, 10 dextrose, and pH 7.4. 
Sucrose Gap Recordings 
A modified sucrose gap technique was used to measure both membrane potentials 
and compound action potentials (Kocsis & Waxman, 1983). Use of this technique 
requires placement of two extracellular electrodes in opposing compartments. Spinal 
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roots were placed across three superfusion compartments of a plexiglass chamber with 
the proximal end of the root relative to the spinal cord placed in the test compartment. 
The roots were sealed into place at the two junctions between compartments with 
petroleum jelly (Figure 1). All chambers were perfused individually at a constant flow 
rate of 1-2 milliliters per minute. In the test compartment, the Krebs’ solution produces 
a physiologic medium in the test compartment to which drugs could be added. The 
isotonic sucrose solution in the middle compartment acts as a high resistance medium 
forcing all currents generated in the test chamber to flow through the cytoplasm of the 
axons in the spinal root toward the reference chamber. The reference chamber was 
perfused with isotonic-KCl solution for the purpose of depolarizing the neurons, thereby 
allowing an extracellular electrode placed in the bath to act as if intracellular. The 
reference chamber electrode and the test chamber electrode together measured the relative 
potential difference between bath and cytoplasm. 
A variable current was delivered to the spinal root in the test compartment 
through a bipolar Teflon-coated stainless steel electrode. The current was generated in 
a stimulus isolator unit (Model 850A; W-P Instruments, Inc.) that was connected to an 
interval generator (Model 830; W-P Instruments, Inc.) and a pulse module (Model 831; 
W-P Instruments, Inc.). Compound action potentials and DC membrane potentials were 
recorded across the two outer compartments through Ag-AgCl electrodes embedded in 
agar (dissolved in 3 M KC1), and connected to a high input impedance DC-coupled 
differential amplifier (Axoprobe 1A; Axon Instruments). Output was sent to a VCR 
storage device (Neuro-Corder Model DR-886; Neuro Data Instruments Corp.), an 
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Isotonic-KCI Isotonic Sucrose Kreb’s 
(reference) (resistance/gap) (test) 
Figure 1: Schematic diagram depicting a dorsal root sealed across the three 
compartments of the modified sucrose gap chamber with the placement of a bipolar 
stimulating electrode in the test compartment. 
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oscilloscope (Model 5440; Tektronix, Inc.), and a chart recorder (Model R4-160VS; 
MFE Corp.) as real-time tracings with a millivolt scale as the ordinate. The magnitude 
of the initial compound action potentials was used as a screening method to ensure the 
use of healthy neurons. Roots whose compound action potentials were greater than 
twenty millivolts were used. 
Statistical Analysis 
Statistical significance of the difference in mean values (with standard errors) of 
the depolarizations was determined using analysis of variance (ANOVA). Significance 
was noted when the p value was less than 0.05. The designation of one week includes 
data from P-7 and P-8 rats, two weeks from P-13, P-14, and P-15 rats, and four weeks 
from P-27 and P-28 rats. Depolarizations were expressed as mean + standard error. 
Project Responsibility 
The author (Sean P. Roddy) performed this project under the supervision of 
Jeffery D. Kocsis, Ph.D. (Professor of Neurology), at the Neuroscience Research Center 
of the West Haven VA Medical Center in a laboratory that was evaluating GABAa 
receptor plasticity in development and regeneration. Within this broad context, a smaller 
project was designed and carried out by the author. Dissections, solution preparation, 
and data analysis were performed by the author. Also, the sucrose gap apparatus 
including the gap chamber, electrodes, oscilloscope, amplifier, and chart recorder were 




The effect of GABA and related drugs on reactivity of rat spinal roots was studied 
during the course of maturation. GABA both decreased the absolute amplitude of the 
compound action potential (CAP) and produced an age-dependent depolarization in 
lumbar dorsal roots. Compound action potentials were generated by stimulation of the 
spinal root axons in the test chamber of the sucrose gap with a bipolar electrode and 
recorded across the two outer compartments. Recordings in dorsal spinal roots 
demonstrated a characteristic rise, peak amplitude, and exponential decay as described 
by Bhisitkul et al., (1987). The recordings had amplitudes of 20-30 mV in the first two 
weeks of life but increased to 40-50 mV at four weeks of age. Half-widths (width of an 
action potential at a point halfway between baseline and peak) of these CAP’S averaged 
1.0-1.2 milliseconds at one week of age and 0.8-1.0 milliseconds at two and four weeks 
of age. 
The decrease in the magnitude of the dorsal root CAP occurred immediately after 
introduction of GABA to the test compartment. Notice the depolarizing shift in baseline 
of the GABA-applied tracing in Figure 2A. Since the peak of the CAP did not shift, the 
reduction in absolute amplitude must have resulted from the membrane depolarization. 
After application of GABA, half-widths were somewhat increased and decay was slightly 
prolonged. The difference in membrane potential between a control and GABA-perfused 
dorsal root was maintained after generation of a CAP. 




Figure 2: (A) The compound action potentials of lumbar dorsal root demonstrating the 
decrease in absolute amplitude after the administration of 1 mM GABA in a P-28 rat. 
The arrow indicates the action potential in the presence of GABA. NS denotes normal 
(Krebs’) solution. (B) DC recordings of the membrane potential in P-7, P-16, and P-28 




amplitude at the age of one week, two weeks, and four weeks (p< 0.0001) (Figure 2B). 
Specifically, these depolarizations seen after application of 1 mM GABA had values of 
2.51 ± 0.14 (n = 11) at one week, 1.16 + 0.09 (n = 11) at two weeks, and 5.60 ± 0.40 
(n=3) at four weeks. However, the potential change observed at age four weeks was no 
different than that of a ten week-old adult rat indicating maturation of the GABA 
response by four weeks. There was a decrease in the magnitude of the depolarization 
between one and two weeks of age by 54% but an increase between two and four weeks 
such that the magnitude of the depolarization in the four week-old is 223% of that in the 
one week-old. A summary of dorsal root depolarization in response to perfusion with 
1 mM GABA is shown in Figure 3. 
In the one week-old rat, there was a rapid time to peak depolarization. However, 
the peak level of depolarization was not maintained and the membrane potential decayed 
quickly to a new plateau level that remained above the original baseline. The two week- 
old had a less rapid time to peak. Unlike the one week-old, the membrane potential at 
peak depolarization at two weeks was maintained throughout application of GABA. The 
four week-old had a similar pattern of GABA-induced depolarization as in the two week- 
old. However, the four week-old had the slowest time to peak and the largest 
depolarization in response to GABA. Dorsal roots in rats between two and four weeks 
of age produced progressively increasing amplitudes of depolarization to GABA with 
maturation. The maximum response to GABA was seen in the four week-old. The 
depolarization in the one week-old was 45 % of that at four weeks and in the two week- 
old was 21% of that at four weeks. 
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1 mM GABA 
Age (days) 
Figure 3: Mean peak depolarization in membrane potential (with bars denoting standard 
error) after application of 1 mM GABA to rat dorsal root. 
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It has been shown that the depolarizing action of GABA on adult rat dorsal root 
is due to the GABAa receptor. To determine GABA receptor subtypes in the neonate, 
experiments used specific GABAa and GABAb agonists and antagonists. The GABAa 
receptor agonist, muscimol, at a concentration of 1 mM produced a peak depolarization 
in the dorsal root at one week of 2.60 ± 0.31 mV (n=3), at two weeks of 1.45 ± 0.17 
mV (n=4), and at four weeks of 4.60 ± 0.14 mV (n=2) (Figure 4A). These values are 
not statistically different from those produced by GABA at equivalent ages. 
Depolarizations by muscimol have similar times to peak as those produced by GABA and 
the amplitudes of depolarization and plateau levels were consistent. A summary of dorsal 
root depolarization in response to perfusion with 1 mM muscimol is shown in Figure 5. 
Since a GABAa agonist produced a response, a competetive GABAa antagonist 
in the presence of GABA should decrease maximal response. Therefore the GABAa 
antagonist, bicuculline, was used in conjunction with GABA to examine competitive 
blockade of the GABAa receptor in the postnatal period. Dorsal roots in the sucrose gap 
chamber were perfused with 100 /xM bicuculline for twenty minutes prior to application 
of 1 mM GABA. This produced peak depolarizations at one week of 1.35 ± 0.17 mV 
(n=4), at two weeks of 0.56 ± 0.17 mV (n=5), and at P-28 of 2.40 ± 0.28 mV (n=2) 
(Figure 4B). In all three age categories, a statistically significant decrease was 
demonstrated in the amplitude of peak depolarization when compared to GABA alone. 
The depolarizations produced by GABA in the presence of bicuculline were 43-54% of 
those produced by GABA alone at any given age. To determine GABAb receptor effects 




ImM Muscimol ImM GABA & 10Q|iM Bicuculline 
Figure 4: (A) Effect of muscimol (1 mM), a GABAa agonist. (B) Effect of GABA (1 
mM) after a 20 minute infusion of bicuculline (100 p.M), a GABAa antagonist. All 
figures are DC recordings of relative membrane potential. Infusion of each drug is 
begun at the arrow. 
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1 mM Muscimol 
Figure 5: Mean peak depolarization in membrane potential (with bars denoting standard 
error) after application of 1 mM muscimol to rat dorsal root. 
I 
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agonist. Application of baclofen to the dorsal root produced no change in resting 
membrane potential at both ages P-5 (n=4) and P-14 (n=4) (Figure 6A). This implies 
that GABAa and not GABAb receptors are involved in depolarization of dorsal root axons 
from birth to adulthood. 
GABA uptake and release mechanisms that have been shown to exist centrally in 
the neonatal optic nerve were examined in the peripheral nervous system by application 
of 1 mM NPA to neonatal dorsal root. NPA stimulates release of endogenous GABA 
and blocks uptake mechanisms (Johnston et al., 1976, Brown et al., 1980). However, 
application of NPA on dorsal roots demonstrated no effect at both P-7 (n=4) and P-14 
(n=4) (Figure 6B). This indicates that endogenous GABA does not play a role in 
determining axonal excitability. To determine if there is selective expression of GABAa 
receptors on sensory and not motor fibers during development of spinal roots, ventral 
roots were tested at both ages P-15 (n=4) and P-37 (n=4). Application of GABA did 
not produce a depolarization with ventral roots (Fig 6C). This indicates that there is 
selective expression of GABAa receptors on primary afferent sensory fibers and not on 
motor fibers during development as well as in adulthood. 
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Figure 6: (A) Effect of baclofen (100 /xM), a GABAb agonist. (B) Effect of NPA (1 
mM). (C) Effect of GABA (1 mM) on ventral roots. All figures are DC recordings of 




GABA has been shown to alter axonal excitability in the developing central 
nervous system through axo-glial interaction in rat optic nerve. GABA also induces a 
GABAa receptor mediated depolarization in optic nerve axons which progressively 
decreases during the first two weeks of life. In contrast, the adult dorsal root axons in 
the peripheral nervous system express GABAa receptors during adulthood. This study 
demonstrated the effects that GABA exerts on membrane potential in dorsal root both 
vary significantly through the first four weeks of life and alter CAP amplitude. 
Additionally, there does not appear to be GABA-mediated modulation of dorsal root 
axonal excitability. 
The results of this study indicate that GABA, through the GABAa receptor, can 
alter both the compound action potential and the membrane potential of rat lumbar dorsal 
spinal root differentially during development. After application of GABA, the absolute 
amplitude of the CAP was decreased but the peak voltage level of the action potential 
was nearly unchanged. Therefore, the GABA-mediated depolarization in baseline 
membrane potential was the cause for a decrease in action potential amplitude. GABA 
brought the membrane potential closer to threshold and, after an adequate excitatory 
current stimulus, the subsequent depolarization from the CAP was somewhat smaller in 
amplitude and larger in half-width. 
The GABA-induced depolarizations observed in this study were mediated by 
GABAa and not GABAb receptors present on primary afferent sensory fibers; GABAa 
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receptor mediated responses were not observed motor fibers. Responses were mimicked 
by the GABAa agonist, muscimol, blocked by the GABAa antagonist, bicuculline, and 
were absent after application of the GABAb agonist, baclofen. Additionally, superfusion 
of GABA to lumbar ventral spinal roots did not alter the membrane potential. 
A significant change in the magnitude of the GABA-mediated depolarization in 
dorsal roots was noted during the first four weeks of life. Initially the amplitude of 
depolarization decreased from one week postnatal to two weeks postnatal but then 
steadily increased until maximum responses were achieved in the fourth week of life. 
Not only did the amplitude of the depolarization change during these first four weeks but 
the characteristics of these depolarizations changed as well. Looking at the one week- 
old, the peak depolarization after application of GABA was not sustained and the 
membrane potential decayed to a lower plateau level that remained above baseline. This 
decay phenomenon is characteristic of desensitization which is common in GABAa 
receptors (Tehrani et al., 1989, White, 1990). Desensitization and a short time-to-peak 
value occurred only during the first week of life. The desensitization and reduction in 
the magnitude of depolarization can have two basic etiologies. First, there may be a 
reduction in expression of the GABAa receptor on the dorsal root axon. A decrease in 
the number of receptors would result in a decreased chloride conductance and a smaller 
depolarization. Alternatively, there may be shielding of axonal GABAa receptors in the 
two week-old by some developing tissue. It is well established that the first and second 
week of life is the time frame in which the process of myelination of the primary afferent 
sensory neurons occurs. Myelin has previously been shown to cover axon regions 
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containing other ion channels. For example, certain types of potassium channels are 
located under the mylein sheath in mammalian axons (Waxman & Ritchie, 1985). Using 
this barrier model, one can assume that GABA diffuses to spinal root axons more readily 
at one week than at two or four weeks of age. In contrast to the one week-old, the 
characteristic shape of the depolarization at two and four weeks of age appear to be 
similar. The responses differ only in the magnitude of the depolarization. This would 
suggest some type of developmental change in a two week time course secondary to an 
increase in GABAa receptor density, to a change in the electrochemical gradient, or to 
a change in the subunit structure of the GABAa receptor. 
There is a transient presence of GABAa receptors in optic nerve during 
development. It has been postulated by Sakatani et al., (1992), that these receptors play 
a role in altering neurite extension at the terminal axons in early development. The 
actions of the growth cone in formation of neuronal terminal arborization patterns and 
coding of information appear to be regulated by calcium levels in the terminal axon 
(Kater et al., 1988). Large increases in the levels of intracellular calcium have been 
found to inhibit growth cone motility and large decreases inhibit neurite outgrowth. It 
appears that a given resting level of calcium is necessary for normal growth cone 
function. Since action potentials depolarize the cell, activate voltage-sensitive calcium 
channels in the terminal axon, and therefore increase calcium levels in the terminal axon, 
neurons in which there is active elongation of the growth cone are sensitive to changes 
induced by action potentials. 
A train of such depolarizations causes cessation of extension of neurites in the 
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growth cone. This is where GABA appears to be important. GABA reduces threshold 
at low concentrations by both depolarizing the axons and increasing conduction velocity 
(Sakatani et al., 1992). Although GABA depolarizes the membrane potential at higher 
concentrations, it also decreases input resistance and allows for shunting of excitatory 
current by an increased chloride conductance. This shunting mechanism clamps the axon 
at a point below threshold. Thus, the level of GABA in the extracellular space has an 
effect on the excitability of the nerve. Low levels would increase the probability of 
producing an action potential and therefore stop neurite extension whereas higher levels 
would inhibit the cell from reaching threshold and allow for continued arborization. 
Endogenous release of GABA from either pre-myelinated axons or glial cells can be 
stimulated by the addition of NPA (in addition to inhibiting GABA uptake) to a central 
nervous system white matter tract such as rat optic nerve in the first week of life. 
However, this is not the case in the peripheral nervous system. Application of NPA to 
rat dorsal root did not effect the resting membrane potential. The glia in the peripheral 
nervous system, namely Schwann cells, do not affect impulse conduction through a 
GABA-mediated increase/decrease in axonal excitability. 
Endogenous sources of GABA which are present and activate GABAa receptors 
in the developing central nervous system optic nerve are absent in the peripheral nervous 
system dorsal spinal roots. GABAa receptors, though capable of modulating axonal 
excitability, do not appear to play a role in the developing dorsal root and its terminal 
arborization patterning. These reults emphasize the regionalization and specificity of 
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